In the November 15, 2005, issue of Blood, Gale et al[1][1] examined the role of stem cell transplantation (SCT) in patients with fetal liver tyrosine kinase 3/internal tandem duplication (FLT3/ITD)-positive acute myeloid leukemia (AML) and concluded that the presence of FLT3/ITD is not an indication
No takes yet. Share an insight, caveat, or question.
Meshinchi et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: